Properties for sale in Glen View, Harare High Density, offer affordable housing options with an average price of $45,000. These properties typically have a median land area of 300 ㎡ and a median building size of around 120 ㎡, with some larger plots reaching up to 20,000 ㎡ and buildings as big as 700 ㎡.
Many homes in Glen View come with essential services such as good ZESA electricity supply, sewer systems, and municipal water, making them practical choices for families and individuals. The properties range from smaller plots to more spacious ones, catering to a variety of needs within this vibrant suburb.
Glen View is a lively high-density area known for its strong community feel and affordability. Residents have access to Glen View Stadium for sports and events, and the nearby Mukuvisi Woodlands offers outdoor recreation. The suburb includes key facilities like Glen View High School and Glen View Clinic, as well as shopping at Glen View Shopping Centre and informal markets. Good public transport links connect the area to central Harare, making it convenient for commuting and daily activities.
| Type | Avg. price |
|---|---|
| Overall | $45,000 |
| Houses (View 20 properties) | $45,000 |
| Land (View 9 properties) | $16,200 |
| Commercial Property (View 6 properties) | $1,090,000 |
Prices as of October 2026
Buying a housing stand in Zimbabwe? Inspect title deeds, subdivision permits, compliance certificates, and seller IDs before making any payment.
Can someone claim your land in Zimbabwe? Learn how 30 year acquisitive prescription works, the legal risks involved, and how to protect your property title.
Explore October 2026 Property Pulse insights on the Zimbabwean real estate market, where high buyer demand outpaces limited housing supply across major areas.
Built a house on land registered in your partner's name? Learn your legal rights in Zimbabwe, tacit universal partnerships, and unjust enrichment claims.
Planning to convert or buy commercial property? Understand Zimbabwe’s change of use rules, 2026 Harare fees, timelines and approval risks.